Skip to Content

APO F43 (Fenofibrate (Micronized) 43 mg)

Pill with imprint APO F43 is Green & White, Capsule-shape and has been identified as Fenofibrate (micronized) 43 mg. It is supplied by Apotex Corp..

Fenofibrate is used in the treatment of hypertriglyceridemia; hyperlipoproteinemia; hyperlipoproteinemia type iia, elevated ldl; hyperlipoproteinemia type iv, elevated vldl; hyperlipoproteinemia type iib, elevated ldl vldl (and more), and belongs to the drug class fibric acid derivatives. Risk cannot be ruled out during pregnancy. Fenofibrate 43 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for APO F43

Fenofibrate (micronized)

Imprint:
APO F43
Strength:
43 mg
Color:
Green & White
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Fibric acid derivatives
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Apotex Corp.
National Drug Code (NDC):
60505-3120

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2018 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide